Skip to main content
. 1997 Nov 1;17(21):8476–8490. doi: 10.1523/JNEUROSCI.17-21-08476.1997

Table 4.

The percentage of BDNF-immunoreactive DRG cells that also express trkA, trkB, or trkC mRNA

% of BDNF expressing trk % of trk expressing BDNF
BDNF and trkA mRNA 85% (583/684) 82% (583/706)
BDNF and trkB mRNA 2.5% (18/708) 9.5% (18/179)
BDNF and trkC mRNA 6% (53/842) 13% (53/399)

Intrathecal NGF treatment. The figures in brackets indicate the number of cells counted.